Business Context and Reporting Period
Company: WiSA Technologies, Inc. (Note: Input metadata referenced "Datavault AI Inc.", but the filing text identifies the registrant as WiSA Technologies, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: January 22, 2024
Reporting Period: Event date January 22, 2024; Expected closing January 23, 2024.
Context: The Company entered into Securities Purchase Agreements with four accredited investors to raise capital via a private placement of promissory notes and warrants.
Key Financial Metrics and Transaction Details
- Gross Proceeds: $600,000 (before fees and expenses).
- Debt Instrument: Promissory Notes with an aggregate principal amount of $1,000,000.
- Equity Instrument: Warrants to purchase up to 10,000,000 shares of Common Stock.
- Warrant Exercise Price: $0.1482 per share.
- Interest Rate: 0% (Notes do not bear interest unless an Event of Default occurs).
- Maturity Date: July 17, 2024, or earlier upon full/partial exercise of specific Series B Convertible Preferred Stock warrants.
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes and Transaction Structure
The filing reports the entry into a material definitive agreement creating a direct financial obligation. Key structural terms include:
- Repayment Terms: The Company may prepay the Notes in whole or in part at any time without penalty or premium upon one day's written notice.
- Warrant Exercisability: Warrants are not exercisable until stockholder approval is obtained for the issuance of shares and, if necessary, an amendment to the certificate of incorporation to increase authorized capital or effectuate a reverse stock split.
- Expiration: Warrants expire five years after stockholder approval is received.
- Beneficial Ownership Limitations: Investors are limited to exercising warrants such that they do not beneficially own more than 4.99% (or 9.99% upon election) of outstanding Common Stock.
- Downward Adjustment: The Exercise Price is subject to downward adjustment if the Company issues securities at a lower price in subsequent transactions.
Guidance, Risks, and Contingencies
- Stockholder Approval Requirement: The Company covenanted to hold an annual or special meeting of stockholders on or prior to March 4, 2024, to obtain necessary approvals for the Warrant Shares.
- Registration Statement: The Company must file a registration statement for the resale of Warrant Shares within 45 days of obtaining stockholder approval.
- Events of Default: Include failure to pay principal, breach of covenants, or bankruptcy/insolvency. Upon default, investors may demand immediate full repayment.
- Listing Risk: Forward-looking statements highlight the risk of the Company's ability to maintain its listing on the Nasdaq Capital Market.
- Financial Metrics: The filing does not provide current revenue, profit, cash flow, or margin data. It focuses solely on the financing transaction.
Investor Verification Checklist
- Verify the outcome of the stockholder meeting scheduled on or before March 4, 2024, regarding the approval of Warrant Shares.
- Confirm the actual net proceeds received after deducting transaction fees and expenses from the $600,000 gross amount.
- Monitor the Company's ability to maintain its Nasdaq Capital Market listing, as failure to do so could impact the value of the warrants.
- Review the full text of the Promissory Note and Warrant forms (Exhibits 4.1 and 4.2) for specific default triggers and adjustment mechanisms.
- Check for any subsequent equity issuances that might trigger a downward adjustment of the $0.1482 warrant exercise price.